121577-32-0

Basic information

• Product Name: Gatifloxacinacid
• Synonyms: Gatifloxacinacid;3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-, Monohydrochloride (9CI);3-Quinolinecarboxylicacid,1-cyclopropyl-6-fluoro-1,4-dihydro-8-Methoxy-7-(3-Methyl-1-piperazinyl)-4-oxo-,hydrochloride (1:1)
• CAS NO: 121577-32-0
• Molecular Formula: C19H22FN3O4.ClH
• Molecular Weight: 411.859
• Mol File: 121577-32-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Gatifloxacinacid(CAS DataBase Reference)
• NIST Chemistry Reference: Gatifloxacinacid(121577-32-0)
• EPA Substance Registry System: Gatifloxacinacid(121577-32-0)

Safety Data

• Hazardous Substances Data: 121577-32-0(Hazardous Substances Data)

Usage

Uses

Used in Medical Applications:
Gatifloxacinacid is used as an antibiotic for treating various bacterial infections, including bronchitis, pneumonia, and urinary tract infections. Its effectiveness in these applications is due to its ability to inhibit bacterial DNA synthesis, thereby killing the bacteria and preventing the infection from spreading.
Used in Pharmaceutical Industry:
Gatifloxacinacid is used as a key component in the formulation of medications designed to combat bacterial infections. Its role in these formulations is to provide a potent antibacterial effect, which is crucial for the treatment of a variety of conditions caused by bacteria.
However, it is important to note that Gatifloxacin and other fluoroquinolones must be used with caution due to the potential for severe side effects. These can include tendonitis, peripheral neuropathy, and central nervous system effects. In some cases, they may also lead to cardiotoxicity and phototoxicity, which underscores the need for careful consideration and monitoring when prescribing and using these drugs.